Skip to main content
. Author manuscript; available in PMC: 2017 Apr 28.
Published in final edited form as: Circulation. 2013 Dec 18;129(3):e28–e292. doi: 10.1161/01.cir.0000441139.02102.80

Table 24-1.

Estimated Direct and Indirect Costs (in Billions of Dollars) of CVD and Stroke: United States, 2010

Heart Disease* Stroke Hypertensive Disease Other Circulatory Conditions Total CVD
Direct costs
 Hospital inpatient stays 67.4 12.2 5.4 13.0 98.0
 Hospital emergency department visits 5.6 1.7 0.9 0.5 8.7
 Hospital outpatient or office-based provider visits 19.3 2.6 13.0 7.3 42.2
 Home health care 5.0 2.9 3.3 0.5 11.7
 Prescribed medicines 9.9 1.2 20.3 1.4 32.8
 Total expenditures 107.2 20.6 42.9 22.7 193.4
Indirect costs§
 Lost productivity/mortality|| 97.2 15.9 3.5 5.3 122.0
Grand totals 204.4 36.5 46.4 28.0 315.4

Numbers do not add to total because of rounding.

CVD indicates cardiovascular disease.

*

This category includes coronary heart disease, heart failure, part of hypertensive disease, cardiac dysrhythmias, rheumatic heart disease, cardiomyopathy, pulmonary heart disease, and other or ill-defined heart diseases.

Costs attributable to hypertensive disease are limited to hypertension without heart disease.

Medical Expenditure Panel Survey healthcare expenditures are estimates of direct payments for care of a patient with the given disease provided during the year, including out-of-pocket payments and payments by private insurance, Medicaid, Medicare, and other sources. Payments for over-the-counter drugs are not included. These estimates of direct costs do not include payments attributed to comorbidities. Total CVD costs are the sum of costs for the 4 diseases but with some duplication.

§

The Statistics Committee agreed to suspend the presentation of estimates of lost productivity attributable to morbidity until a better estimating method can be developed.

||

Lost future earnings of people who died in 2010, discounted at 3%.

Sources: Estimates from the Household Component of the Medical Expenditure Panel Survey of the Agency for Healthcare Research and Quality for direct costs (2010).1 Indirect mortality costs are based on 2010 counts of deaths by the National Center for Health Statistics and an estimated present value of lifetime earnings furnished for 2009 by Wendy Max (Institute for Health and Aging, University of California, San Francisco, April 25, 2012) and inflated to 2010 from change in worker compensation reported by the US Bureau of Labor Statistics.

All estimates prepared by Michael Mussolino, National Heart, Lung, and Blood Institute.